|
1
|
Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci.
|
Cancer Res
|
2007
|
3.25
|
|
2
|
Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients.
|
Ann Intern Med
|
2006
|
2.85
|
|
3
|
Safety and immunologic effects of IL-15 administration in nonhuman primates.
|
Blood
|
2009
|
2.00
|
|
4
|
Contribution of transplanted bone marrow cells to Purkinje neurons in human adult brains.
|
Proc Natl Acad Sci U S A
|
2003
|
1.99
|
|
5
|
Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection.
|
Blood
|
2007
|
1.85
|
|
6
|
Development and optimization of quantitative PCR for the diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.
|
BMC Infect Dis
|
2008
|
1.70
|
|
7
|
Quantitative real-time polymerase chain reaction for detection of adenovirus after T cell-replete hematopoietic cell transplantation: viral load as a marker for invasive disease.
|
Clin Infect Dis
|
2007
|
1.66
|
|
8
|
Toxicity and efficacy of daily dapsone as Pneumocystis jiroveci prophylaxis after hematopoietic stem cell transplantation: a case-control study.
|
Biol Blood Marrow Transplant
|
2005
|
1.65
|
|
9
|
Phenotypic analysis of mice lacking the Tmprss2-encoded protease.
|
Mol Cell Biol
|
2006
|
1.44
|
|
10
|
Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation.
|
Blood
|
2003
|
1.31
|
|
11
|
Phase II trial of intravenous CI-1042 in patients with metastatic colorectal cancer.
|
J Clin Oncol
|
2003
|
1.21
|
|
12
|
MyD88 signaling contributes to early pulmonary responses to Aspergillus fumigatus.
|
Infect Immun
|
2007
|
1.20
|
|
13
|
Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants.
|
Blood
|
2003
|
1.19
|
|
14
|
Tissue inhibitor of metalloproteinase-1 deficiency amplifies acute lung injury in bleomycin-exposed mice.
|
Am J Respir Cell Mol Biol
|
2005
|
1.17
|
|
15
|
Refractory colitis following anti-CTLA4 antibody therapy: analysis of mucosal FOXP3+ T cells.
|
Dig Dis Sci
|
2009
|
1.15
|
|
16
|
Interleukin-7 improves CD4 T-cell reconstitution after autologous CD34 cell transplantation in monkeys.
|
Blood
|
2003
|
1.13
|
|
17
|
Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival.
|
Biol Blood Marrow Transplant
|
2003
|
1.12
|
|
18
|
Tissue inhibitor of metalloproteinase-1 moderates airway re-epithelialization by regulating matrilysin activity.
|
Am J Pathol
|
2008
|
1.02
|
|
19
|
Marrow fibrosis as a risk factor for posttransplantation outcome in patients with advanced myelodysplastic syndrome or acute myeloid leukemia with multilineage dysplasia.
|
Biol Blood Marrow Transplant
|
2007
|
1.00
|
|
20
|
Developing a comprehensive mouse pathology program.
|
Comp Med
|
2004
|
0.99
|
|
21
|
Adenovirus nephritis in hematopoietic stem-cell transplantation.
|
Transplantation
|
2004
|
0.98
|
|
22
|
Training mouse pathologists: five years of pathology of mouse models of human disease workshops.
|
Toxicol Pathol
|
2007
|
0.97
|
|
23
|
Adenoviral graft-nephritis: case report and review of the literature.
|
Transpl Int
|
2009
|
0.95
|
|
24
|
Reduced expression of inducible gelatinase B/matrix metalloproteinase-9 in monocytes from patients with myelodysplastic syndrome: Correlation of inducible levels with the percentage of cytogenetically marked cells and with marrow cellularity.
|
Blood
|
2007
|
0.91
|
|
25
|
Induction of apoptosis using inhibitors of lysophosphatidic acid acyltransferase-beta and anti-CD20 monoclonal antibodies for treatment of human non-Hodgkin's lymphomas.
|
Clin Cancer Res
|
2005
|
0.86
|
|
26
|
Blood and gastric FOXP3+ T cells are not decreased in human gastric graft-versus-host disease.
|
Biol Blood Marrow Transplant
|
2010
|
0.86
|
|
27
|
Langerhans cell homeostasis and turnover after nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation.
|
Transplantation
|
2014
|
0.85
|